title: Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG Trial.
authors.forename: Barbara E
authors.initials: BE
authors.lastname: Stähli
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Tardif
authors.forename: Michel
authors.initials: M
authors.lastname: Carrier
authors.forename: Richard
authors.initials: R
authors.lastname: Gallo
authors.forename: Robert W
authors.initials: RW
authors.lastname: Emery
authors.forename: Stephen
authors.initials: S
authors.lastname: Robb
authors.forename: Daniel
authors.initials: D
authors.lastname: Cournoyer
authors.forename: Lucie
authors.initials: L
authors.lastname: Blondeau
authors.forename: Dominique
authors.initials: D
authors.lastname: Johnson
authors.forename: Jessica
authors.initials: J
authors.lastname: Mann
authors.forename: Jacques
authors.initials: J
authors.lastname: Lespérance
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Guertin
authors.forename: Philippe L
authors.initials: PL
authors.lastname: L'Allier
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000009:adverse effects; D017023:Coronary Angiography / Q000379:methods; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000037:antagonists & inhibitors*; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D002317:Cardiovascular Agents; D019007:P-Selectin; C000604431:inclacumab